In addition to RanBP2 mutations, HLA, CPT2, SCN1A, and SLC19A3 mutations have been associated with influenza or COVID-19-associated ANE (Table 1) [53,55,57,59,93,94,95]. This evidence concerns the gene RANBP2 and influenza.